Small clinical study· 1997

Effectiveness of Semax in the acute period of hemispheric ischemic stroke

Gusev EI|et al.

Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova

PubMed: 11517472
Evidence level: low
Verification: verified

Summary

Study of Semax in 30 patients during acute hemispheric ischemic stroke.

Limitations

Small sample|Regional publication|Limited accessible methodological detail|No modern independent replication

Linked peptides

Semax

Important PeptiBrief is an educational information platform. It does not diagnose, prescribe, sell peptides, recommend dosing, encourage self-experimentation or replace qualified medical care. Published scientific evidence is kept separate from community observations and uncertainty.